Potential Health Effects
The toxicological properties of this material have not been
investigated. Use appropriate procedures to prevent opportunities
for direct contact with the skin or eyes and to prevent inhalation.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Not available.
Skin:
Not available.
Ingestion:
Not available.
Inhalation:
Not available.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
Not available.
Extinguishing Media:
Not available.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Not available.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Not available.
Storage:
Not available.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Exposure Limits
CAS# 7789-61-9:
United Kingdom, WEL - TWA: (listed as antimony compounds): 0.5 mg
TWA (except stibine, as Sb)
United Kingdom, WEL - STEL: (listed as antimony compounds): 1.5 m
STEL (except stibine, as Sb)
United States OSHA: 0.5 mg/m3 TWA (listed under Antimony).0.5 mg
TWA (as Sb) (listed under Antimony compounds).
Belgium - TWA: (listed as antimony compounds): 0.5 mg/m3 VLE (as
France - VME: (listed as antimony compounds): 0.5 mg/m3 VME (as S
Germany: (listed as antimony compounds): 0.5 mg/m3 VME (as Sb)
Japan: (listed as antimony compounds): 0.1 mg/m3 OEL (except stib
as Sb)
Malaysia: (listed as antimony compounds): 0.5 mg/m3 TWA (as Sb)
Netherlands: (listed as antimony compounds): 0.5 mg/m3 MAC (as Sb
Russia: (listed as antimony): 0.5 mg/m3 TWA
Russia: (listed as antimony): 0.2 mg/m3 STEL
Spain: (listed as antimony compounds): 0.5 mg/m3 VLA-ED (except
antimony hydride, as Sb)
Personal Protective Equipment
Eyes:
Not available.
Skin:
Not available.
Clothing:
Not available.
Respirators:
Not available.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Not available.
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula:
Molecular Weight:
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Not available.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Not available.
Hazardous Polymerization: Not available.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7789-61-9: CC4400000
LD50/LC50:
Not available.
Carcinogenicity:
Antimony(iii)bromide, 99.99% -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 7789-61-9: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7789-61-9: No information available.
Canada
CAS# 7789-61-9 is listed on Canada's NDSL List.
CAS# 7789-61-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7789-61-9 is listed on the TSCA inventory.
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------